Takeda considers India deals, says report

India's the Economic Times has reported that Takeda is holding talks with India-based generic drug firms Cipla and Lupin

Takeda Pharmaceutical Company is reportedly in takeover talks with India-based generic drug manufacturers Cipla and Lupin, according to the Economic Times.

Takeda, which has said it wants to expand in India, one of the world's fastest growing drug markets, has reportedly held preliminary talks with Cipla, while talks with Lupin have progressed beyond the initial stage.

The newspaper, which cited individuals with direct knowledge of the development, could not confirm the story with official representatives of the companies. It did, however, quote a Cipla spokeswoman: "We would like to clarify that these reports are baseless and untrue and is categorically denied."

The Economic Times said that Takeda was interested in buying Lupin's domestic formulations business, as well as its research facility, but its founders were not willing to sell the research unit.

Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...